Literature DB >> 11724894

First European pediatric case of human granulocytic ehrlichiosis.

M Arnez1, M Petrovec, S Lotric-Furlan, T A Zupanc, F Strle.   

Abstract

Herein we report on the first confirmed pediatric case of acute human granulocytic ehrlichiosis in Europe. Presentation in this 11-year-old girl was comparable to clinical findings seen in adult European patients with human granulocytic ehrlichiosis; i.e., she had self-limited febrile illness with leukopenia, thrombocytopenia, and elevated serum C-reactive protein concentration. It is of interest that the patient not only had a fourfold change in antibody titer to Ehrlichia phagocytophila but also developed antibodies to Ehrlichia chaffeensis and that her PCR test result was positive on the third as well as on the 22nd day after the onset of illness, that is, 16 days after spontaneous defervescence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724894      PMCID: PMC88598          DOI: 10.1128/JCM.39.12.4591-4592.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

Review 1.  Ehrlichiosis in children.

Authors:  R F Jacobs; G E Schutze
Journal:  J Pediatr       Date:  1997-08       Impact factor: 4.406

2.  Human infection with Ehrlichia canis, a leukocytic rickettsia.

Authors:  K Maeda; N Markowitz; R C Hawley; M Ristic; D Cox; J E McDade
Journal:  N Engl J Med       Date:  1987-04-02       Impact factor: 91.245

3.  Human disease in Europe caused by a granulocytic Ehrlichia species.

Authors:  M Petrovec; S Lotric Furlan; T A Zupanc; F Strle; P Brouqui; V Roux; J S Dumler
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

Review 4.  Human granulocytic ehrlichiosis.

Authors:  J S Bakken; J S Dumler
Journal:  Clin Infect Dis       Date:  2000-09-14       Impact factor: 9.079

5.  Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis.

Authors:  R S Buller; M Arens; S P Hmiel; C D Paddock; J W Sumner; Y Rikhisa; A Unver; M Gaudreault-Keener; F A Manian; A M Liddell; N Schmulewitz; G A Storch
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

6.  Human granulocytic ehrlichiosis presenting as abdominal pain.

Authors:  J C Gershel
Journal:  Pediatrics       Date:  2000-09       Impact factor: 7.124

7.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

8.  Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia.

Authors:  S Lotric-Furlan; M Petrovec; T A Zupanc; W L Nicholson; J W Sumner; J E Childs; F Strle
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

  8 in total
  8 in total

1.  Evolution of antigen variation in the tick-borne pathogen Anaplasma phagocytophilum.

Authors:  Daniel Rejmanek; Patrick Foley; Anthony Barbet; Janet Foley
Journal:  Mol Biol Evol       Date:  2011-09-28       Impact factor: 16.240

2.  Transmission of Anaplasma phagocytophilum from endothelial cells to peripheral granulocytes in vitro under shear flow conditions.

Authors:  Jinyong Wang; Viktor Dyachenko; Ulrike G Munderloh; Reinhard K Straubinger
Journal:  Med Microbiol Immunol       Date:  2015-01-25       Impact factor: 3.402

3.  Identification of Borrelia burgdorferi sensu lato, Anaplasma and Ehrlichia species, and spotted fever group Rickettsiae in ticks from Southeastern Europe.

Authors:  I Christova; J Van De Pol; S Yazar; E Velo; L Schouls
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

4.  High diversity of ankA sequences of Anaplasma phagocytophilum among Ixodes ricinus ticks in Germany.

Authors:  Friederike D von Loewenich; Birgit U Baumgarten; Klaus Schröppel; Walter Geissdörfer; Martin Röllinghoff; Christian Bogdan
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 5.  Ixodes ricinus and Its Transmitted Pathogens in Urban and Peri-Urban Areas in Europe: New Hazards and Relevance for Public Health.

Authors:  Annapaola Rizzoli; Cornelia Silaghi; Anna Obiegala; Ivo Rudolf; Zdeněk Hubálek; Gábor Földvári; Olivier Plantard; Muriel Vayssier-Taussat; Sarah Bonnet; Eva Spitalská; Mária Kazimírová
Journal:  Front Public Health       Date:  2014-12-01

6.  Circulation of four Anaplasma phagocytophilum ecotypes in Europe.

Authors:  Setareh Jahfari; E Claudia Coipan; Manoj Fonville; Arieke Docters van Leeuwen; Paul Hengeveld; Dieter Heylen; Paul Heyman; Cees van Maanen; Catherine M Butler; Gábor Földvári; Sándor Szekeres; Gilian van Duijvendijk; Wesley Tack; Jolianne M Rijks; Joke van der Giessen; Willem Takken; Sipke E van Wieren; Katsuhisa Takumi; Hein Sprong
Journal:  Parasit Vectors       Date:  2014-08-15       Impact factor: 3.876

7.  Assessment of antibodies against surface and outer membrane proteins of Anaplasma phagocytophilum in Lyme borreliosis and tick-borne encephalitis paediatric patients.

Authors:  L Krbková; L Homola; A Hlaváčová; P Mikolášek; J Bednářová; Z Čermáková
Journal:  Epidemiol Infect       Date:  2016-05-16       Impact factor: 4.434

Review 8.  A review on the eco-epidemiology and clinical management of human granulocytic anaplasmosis and its agent in Europe.

Authors:  Ioana A Matei; Agustín Estrada-Peña; Sally J Cutler; Muriel Vayssier-Taussat; Lucía Varela-Castro; Aleksandar Potkonjak; Herve Zeller; Andrei D Mihalca
Journal:  Parasit Vectors       Date:  2019-12-21       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.